Cancer Immunotherapy Flashcards

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/19

flashcard set

Earn XP

Description and Tags

A set of flashcards covering key concepts and vocabulary related to cancer immunotherapy.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

20 Terms

1
New cards

Immune surveillance

The immune system's ability to detect and destroy emerging tumor cells.

2
New cards

Tumor-specific antigens (TSAs)

Antigens unique to tumor cells, not found on normal cells (e.g., mutated p53, viral antigens like HPV E6/E7).

3
New cards

Tumor-associated antigens (TAAs)

Normal proteins expressed abnormally or in excess by tumor cells (e.g., HER2, CEA, AFP).

4
New cards

CD8+ T cells

Cells that recognize tumor peptides on MHC I and kill tumor cells through cytotoxic granules.

5
New cards

NK cells

Natural Killer cells that kill tumor cells that have downregulated MHC I (missing-self recognition).

6
New cards

Tumor immune evasion

Methods used by tumors to evade the immune system, including downregulating MHC I and secreting immunosuppressive cytokines.

7
New cards

PD-1/PD-L1 interaction

Inhibits T cell activity, allowing tumors to escape immune destruction.

8
New cards

Checkpoint blockade therapy

Uses antibodies to block inhibitory receptors (PD-1, CTLA-4), restoring T cell activity.

9
New cards

CTLA-4 inhibitor

Ipilimumab, a drug used in cancer therapy.

10
New cards

PD-1 inhibitor

Nivolumab or Pembrolizumab, used in cancer therapy.

11
New cards

PD-L1 inhibitor

Atezolizumab, which blocks tumor PD-L1 from binding PD-1.

12
New cards

Monoclonal antibodies

Antibodies that bind tumor antigens, leading to ADCC, opsonization, or receptor blockade.

13
New cards

Trastuzumab

A monoclonal antibody that targets HER2 in breast cancer.

14
New cards

CAR-T cell therapy

T cells engineered to express a chimeric antigen receptor targeting tumor antigens (e.g., CD19).

15
New cards

Cytokine release syndrome (CRS)

A risk associated with CAR-T therapy.

16
New cards

Cytokine therapy

The goal is to boost immune activation, e.g., IL-2 to expand CD8+ T cells.

17
New cards

IL-2

The cytokine used for melanoma treatment.

18
New cards

IFN-alpha

Enhances MHC I expression and promotes anti-tumor immunity.

19
New cards

Cancer vaccine

A vaccine targeting tumor antigens, such as the HPV vaccine targeting HPV E6/E7 proteins.

20
New cards

Immunoediting

The process by which tumors evolve under immune pressure: elimination, equilibrium, escape.